Satellos Bioscience Inc. Cash And Cash Equivalents
Satellos Bioscience Inc. (MSLE) had Cash And Cash Equivalents of $9.80 million as of 2025-12-31, per its 40-F filed 2026-03-27.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2026-03-27
- 2024-12-31: Cash And Cash Equivalents 57.66M CAD.
- 2023-12-31: Cash And Cash Equivalents 22.07M CAD.
CAD
| Period end | Cash And Cash Equivalents |
|---|---|
| 2024-12-31 | 57.66M CAD 40-F · filed 2026-03-27 |
| 2023-12-31 | 22.07M CAD 40-F · filed 2026-03-27 |
USD
| Period end | Cash And Cash Equivalents |
|---|---|
| 2025-12-31 | $9.80M 40-F · filed 2026-03-27 |
| 2024-12-31 | $40.07M 40-F · filed 2026-03-27 |
| 2023-12-31 | $16.68M 40-F · filed 2026-03-27 |